Correction: Urokinase redux: route, compartment, access, and pharmacological evolution from native urokinase to recombinant prourokinase.

Frontiers Production Office

Open source

DOI
10.3389/fcvm.2026.2017216
Published
2026
Container
Frontiers in cardiovascular medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2026.2017216,
  title = {Correction: Urokinase redux: route, compartment, access, and pharmacological evolution from native urokinase to recombinant prourokinase.},
  author = {Frontiers Production Office},
  year = {2026},
  journal = {Frontiers in cardiovascular medicine},
  doi = {10.3389/fcvm.2026.2017216},
  url = {https://doi.org/10.3389/fcvm.2026.2017216}
}

RIS

TY  - JOUR
TI  - Correction: Urokinase redux: route, compartment, access, and pharmacological evolution from native urokinase to recombinant prourokinase.
AU  - Frontiers Production Office
PY  - 2026
JO  - Frontiers in cardiovascular medicine
DO  - 10.3389/fcvm.2026.2017216
UR  - https://doi.org/10.3389/fcvm.2026.2017216
ER  - 

APA

Office, F. P. (2026). Correction: Urokinase redux: route, compartment, access, and pharmacological evolution from native urokinase to recombinant prourokinase.. Frontiers in cardiovascular medicine. https://doi.org/10.3389/fcvm.2026.2017216

Source records